BDLIB
Banque de Luxembourg Investments (BLI) Portfolio holdings
AUM
$3.49B
This Quarter Return
+7.43%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.49B
AUM Growth
+$194M
(+5.9%)
Cap. Flow
+$12.6M
Cap. Flow
% of AUM
0.36%
Top 10 Holdings %
Top 10 Hldgs %
31.08%
Holding
179
New
41
Increased
36
Reduced
74
Closed
4
Top Buys
| 1 |
Accenture
ACN
|
+$21.8M |
| 2 |
Meta Platforms (Facebook)
META
|
+$18.9M |
| 3 |
Eli Lilly
LLY
|
+$18.6M |
| 4 |
Applied Materials
AMAT
|
+$16.3M |
| 5 |
Texas Pacific Land
TPL
|
+$14M |
Top Sells
| 1 |
Amazon
AMZN
|
+$25.1M |
| 2 |
Verisk Analytics
VRSK
|
+$24.9M |
| 3 |
Microsoft
MSFT
|
+$22.3M |
| 4 |
Nike
NKE
|
+$21.7M |
| 5 |
Lowe's Companies
LOW
|
+$20.7M |
Sector Composition
| 1 | Technology | 28.32% |
| 2 | Industrials | 15.99% |
| 3 | Healthcare | 15.74% |
| 4 | Consumer Discretionary | 10.06% |
| 5 | Financials | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Williams-Sonoma
WSM
$24.7B
| $2.45M | 0.07% |
+14,900
| New | +$2.45M |
|
152
Applovin
APP
$197B
| $2.34M | 0.07% |
+7,000
| New | +$2.34M |
|
153
Pultegroup
PHM
$27.3B
| $2.3M | 0.07% |
+21,800
| New | +$2.3M |
|
154
Elevance Health
ELV
$71.4B
| $2.29M | 0.07% |
+6,000
| New | +$2.29M |
|
155
Ameriprise Financial
AMP
$47.1B
| $2.27M | 0.07% |
+4,300
| New | +$2.27M |
|
156
Gilead Sciences
GILD
$145B
| $2.22M | 0.06% |
20,031
-1,700
| -8% | -$188K |
|
157
Amgen
AMGN
$151B
| $2.16M | 0.06% |
7,783
| – | – |
|
158
Wells Fargo
WFC
$260B
| $1.99M | 0.06% |
25,000
| – | – |
|
159
Pembina Pipeline
PBA
$22.7B
| $1.97M | 0.06% |
52,700
| – | – |
|
160
Stryker
SYK
$148B
| $1.9M | 0.05% |
4,833
-600
| -11% | -$236K |
|
161
Analog Devices
ADI
$122B
| $1.86M | 0.05% |
7,833
-11,300
| -59% | -$2.68M |
|
162
AbbVie
ABBV
$387B
| $1.82M | 0.05% |
9,999
-1,800
| -15% | -$328K |
|
163
eBay
EBAY
$41.6B
| $1.76M | 0.05% |
23,896
| – | – |
|
164
Johnson Controls International
JCI
$71.1B
| $1.67M | 0.05% |
15,884
| – | – |
|
|
AMRZ
165
Amrize Ltd
AMRZ
$30.6B
| $1.39M | 0.04% |
+28,100
| New | +$1.39M |
|
166
Emerson Electric
EMR
$77.1B
| $1.28M | 0.04% |
9,599
| – | – |
|
167
Keysight
KEYS
$29.6B
| $1.25M | 0.04% |
7,600
-15,300
| -67% | -$2.51M |
|
168
Agilent Technologies
A
$35.6B
| $1.14M | 0.03% |
9,599
| – | – |
|
169
Ecolab
ECL
$77.7B
| $1.1M | 0.03% |
4,100
-5,000
| -55% | -$1.34M |
|
170
JPMorgan Chase
JPM
$841B
| $1.09M | 0.03% |
3,800
| – | – |
|
171
Exxon Mobil
XOM
$480B
| $1.08M | 0.03% |
9,900
| – | – |
|
172
Chevron
CVX
$319B
| $949K | 0.03% |
6,600
| – | – |
|
173
Trex
TREX
$6.59B
| $538K | 0.02% |
9,800
-300
| -3% | -$16.5K |
|
174
Moderna
MRNA
$9.82B
| $369K | 0.01% |
13,600
| – | – |
|
175
Teradyne
TER
$17.9B
| $289K | 0.01% |
3,200
| – | – |
|